Literature DB >> 22103605

Patient-centric clinical pharmacology advances the path to personalized medicine.

Scott A Waldman1, Andre Terzic.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22103605     DOI： 10.2217/bmm.11.78

Source DB:  PubMed          Journal:  Biomark Med        ISSN： 1752-0363            Impact factor:   2.851


× No keyword cloud information.
  4 in total

1.  The value proposition of molecular medicine.

Authors:  Scott A Waldman; Andre Terzic
Journal:  Clin Transl Sci       Date:  2012-02-23       Impact factor: 4.689

Review 2.  Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine.

Authors:  Clara Hartmanshenn; Megerle Scherholz; Ioannis P Androulakis
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-09-19       Impact factor: 2.745

Review 3.  Reverse Translation of US Food and Drug Administration Reviews of Oncology New Molecular Entities Approved in 2011-2017: Lessons Learned for Anticancer Drug Development.

Authors:  Stephanie Faucette; Santosh Wagh; Ashit Trivedi; Karthik Venkatakrishnan; Neeraj Gupta
Journal:  Clin Transl Sci       Date:  2017-12-19       Impact factor: 4.689

4.  Systems approaches evolve clinical pharmacology.

Authors:  S A Waldman; P H van der Graaf; A Terzic
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-08-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.